Caitong International Asset Management’s SOPHiA GENETICS SOPH Stock Holding History

Caitong International Asset Management’s Portfolio SOPH Stock Details SOPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5	Buy	+1	New	+$5	﹤0.01%	2294

Other funds holding SOPH

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Principal Financial Group

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Ensign Peak Advisors

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Caitong International Asset Management's SOPH Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in SOPHiA GENETICS (SOPH) in Q1 2026: 1 share worth $5. The stake represents ﹤0.01% of the portfolio and ranks #2294 among its holdings.

49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

Caitong International Asset Management held 1 share of SOPHiA GENETICS worth $5 as of Q1 2026.
SOPHiA GENETICS was a new Caitong International Asset Management position in Q1 2026.
SOPHiA GENETICS made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2294 holding.
49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.